114 related articles for article (PubMed ID: 4064546)
21. Analysis of failure following definitive radiotherapy for invasive transitional cell carcinoma of the bladder.
Mameghan H; Fisher R; Mameghan J; Brook S
Int J Radiat Oncol Biol Phys; 1995 Jan; 31(2):247-54. PubMed ID: 7836076
[TBL] [Abstract][Full Text] [Related]
22. Treatment outcome and prognostic variables for local control and survival in patients receiving radical radiotherapy for urinary bladder cancer.
Fokdal L; Høyer M; von der Maase H
Acta Oncol; 2004; 43(8):749-57. PubMed ID: 15764221
[TBL] [Abstract][Full Text] [Related]
23. Apoptosis and downstaging after preoperative radiotherapy for muscle-invasive bladder cancer.
Chyle V; Pollack A; Czerniak B; Stephens LC; Zagars GK; Terry NH; Meyn RE
Int J Radiat Oncol Biol Phys; 1996 May; 35(2):281-7. PubMed ID: 8635934
[TBL] [Abstract][Full Text] [Related]
24. Neutron therapy of bladder carcinoma: can a high rate of severe complications be avoided in neutron therapy?
Kirkove C; Richard F; Van Cangh PJ; Ledent G; Octave-Prignot M; Wambersie A
Eur Urol; 1993; 24(1):52-7. PubMed ID: 8365440
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of efficacy and toxicity in two different hypofractionated 3D-conformal external beam radiotherapy schedules in localised muscle invasive bladder cancer.
Kouloulias V; Mosa E; Tolia M; Kantzou I; Koliarakis N; Platoni K; Georgakopoulos I; Siatelis A; Sarris G; Beli I; Chrisofos M; Kelekis N
J BUON; 2013; 18(4):942-8. PubMed ID: 24344021
[TBL] [Abstract][Full Text] [Related]
26. Combined chemotherapy and radiation with selective organ preservation for muscle-invasive bladder carcinoma. A single-institution phase II study.
Fellin G; Graffer U; Bolner A; Ambrosini G; Caffo O; Luciani L
Br J Urol; 1997 Jul; 80(1):44-9. PubMed ID: 9240179
[TBL] [Abstract][Full Text] [Related]
27. Local control of muscle-invasive bladder cancer: preoperative radiotherapy and cystectomy versus cystectomy alone.
Cole CJ; Pollack A; Zagars GK; Dinney CP; Swanson DA; von Eschenbach AC
Int J Radiat Oncol Biol Phys; 1995 May; 32(2):331-40. PubMed ID: 7751174
[TBL] [Abstract][Full Text] [Related]
28. Low-dose-rate brachytherapy is superior to high-dose-rate brachytherapy for bladder cancer.
Pos FJ; Horenblas S; Lebesque J; Moonen L; Schneider C; Sminia P; Bartelink H
Int J Radiat Oncol Biol Phys; 2004 Jul; 59(3):696-705. PubMed ID: 15183473
[TBL] [Abstract][Full Text] [Related]
29. Carcinoma of the bladder treated by interstitial irradiation.
Williams GB; Trott PA; Bloom HJ
Br J Urol; 1981 Jun; 53(3):221-4. PubMed ID: 7248698
[TBL] [Abstract][Full Text] [Related]
30. Accelerated superfractionated radiotherapy with concomitant boost for invasive bladder cancer.
Yavuz AA; Yavuz MN; Ozgur GK; Colak F; Ozyavuz R; Cimsitoglu E; Ilis E
Int J Radiat Oncol Biol Phys; 2003 Jul; 56(3):734-45. PubMed ID: 12788179
[TBL] [Abstract][Full Text] [Related]
31. The normal tissue sparing obtained with simultaneous treatment of pelvic lymph nodes and bladder using intensity-modulated radiotherapy.
Søndergaard J; Høyer M; Petersen JB; Wright P; Grau C; Muren LP
Acta Oncol; 2009; 48(2):238-44. PubMed ID: 18759144
[TBL] [Abstract][Full Text] [Related]
32. Full-dose irradiation for invasive bladder cancer: prognostic factors and techniques.
Shipley WU
Urology; 1984 Apr; 23(4 Suppl):95-100. PubMed ID: 6424299
[No Abstract] [Full Text] [Related]
33. Once weekly irradiation for carcinoma of the bladder.
Rostom AY; Tahir S; Gershuny AR; Kandil A; Folkes A; White WF
Int J Radiat Oncol Biol Phys; 1996 May; 35(2):289-92. PubMed ID: 8635935
[TBL] [Abstract][Full Text] [Related]
34. A randomised trial of accelerated radiotherapy for localised invasive bladder cancer.
Horwich A; Dearnaley D; Huddart R; Graham J; Bessell E; Mason M; Bliss J
Radiother Oncol; 2005 Apr; 75(1):34-43. PubMed ID: 15878099
[TBL] [Abstract][Full Text] [Related]
35. Significance of downstaging in muscle-invasive bladder cancer treated with preoperative radiotherapy.
Pollack A; Zagars GK; Cole CJ; Dinney CP; Swanson DA; Grossman HB
Int J Radiat Oncol Biol Phys; 1997 Jan; 37(1):41-9. PubMed ID: 9054875
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of clinical staging before cystectomy in transitional cell bladder carcinoma: a long-term follow-up of 276 consecutive patients.
Wijkström H; Norming U; Lagerkvist M; Nilsson B; Näslund I; Wiklund P
Br J Urol; 1998 May; 81(5):686-91. PubMed ID: 9634042
[TBL] [Abstract][Full Text] [Related]
37. [Concurrent chemotherapy and hyperfractionated radiotherapy for non-operable carcinoma of the bladder].
Schmitt T; Armand C; Mille D; Favrel-Tchakamian V; Gilloz A
Cancer Radiother; 1998 Apr; 2 Suppl 1():82s-84s. PubMed ID: 9749085
[TBL] [Abstract][Full Text] [Related]
38. [The radiation therapy of bladder cancer in a regimen of nontraditional fractionation with local radiomodification by metronidazole].
Pereslegin IA; Mufazalov FF
Med Radiol (Mosk); 1991; 36(12):26-8. PubMed ID: 1749327
[TBL] [Abstract][Full Text] [Related]
39. A feasibility study of partially accelerated radiotherapy for invasive bladder cancer.
Plataniotis G; Michalopoulos E; Kouvaris J; Vlahos L; Papavasiliou C
Radiother Oncol; 1994 Oct; 33(1):84-7. PubMed ID: 7878215
[TBL] [Abstract][Full Text] [Related]
40. Clinical outcome in patients with locally advanced bladder carcinoma treated with conservative multimodality therapy.
George L; Bladou F; Bardou VJ; Gravis G; Tallet A; Alzieu C; Serment G; Salem N
Urology; 2004 Sep; 64(3):488-93. PubMed ID: 15351577
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
